Cannabigerolic acid

PhytochemicalCannabinoidBest with a meal

What is it

Cannabigerolic acid (CBGA) is the acidic precursor cannabinoid in the cannabis plant from which THCA, CBDA, and CBCA are synthesized. It is found in small amounts in raw, unheated cannabis or hemp.

Evidence for 1 use

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Any claimed clinical benefit

Mixed Evidence

Most evidence is from cell or animal studies. No controlled human trials have established benefit for any specific condition.

How it works

CBGA is the chemical 'parent' cannabinoid. Plant enzymes convert it into other acidic cannabinoids (THCA, CBDA, CBCA) as the plant matures. When cannabis is heated (smoked, vaporized, baked), CBGA is decarboxylated to CBG, but most CBGA itself is lost in the process. In vitro and animal data hint at modest activity on PPAR-gamma receptors and certain enzymes, but human pharmacology of CBGA is poorly characterized. CBGA does not produce a psychoactive 'high.'

Dosage

There is no established human dose. Commercial CBGA products specify amounts ranging from a few milligrams to several tens of milligrams per serving, but dosing is not evidence-based.

When and how to take it

No established timing. Products may be taken with food, since cannabinoids are fat-soluble and food can improve absorption.

1 commercial form

Compare the main delivery options and what they’re best suited for.

CBGA isolate or oil

Sold in hemp and cannabis supplement product lines.

Fat-soluble; absorption improved when taken with a meal containing fat.

Safety

Human safety data for isolated CBGA are very limited. Related cannabinoids are generally well tolerated in short-term use, but the long-term safety of CBGA specifically is unknown. CBGA, like other acidic cannabinoids, can convert to its neutral form (CBG) over time, especially with heat or storage.

Who should be cautious

Avoid in pregnancy and breastfeeding due to lack of safety data. Legality of hemp-derived cannabinoids varies by region. Drug-test sensitivity to CBGA is unclear.

Interactions

Cannabinoids in general can inhibit cytochrome P450 enzymes (especially CYP3A4 and CYP2C9), potentially raising blood levels of certain medications. Specific data for CBGA are lacking. People on prescription medications metabolized by these enzymes should consult a clinician.

Frequently asked questions

Will CBGA make me high?⌄

No. CBGA is non-intoxicating. Some related cannabinoids (like THC) are intoxicating, but CBGA itself is not.

Is CBGA legal where I live?⌄

Laws vary by country and U.S. state. Hemp-derived cannabinoids are widely sold in the U.S. but may not be legal everywhere. Check local rules before purchasing.

References

Cannabigerolic acid on Wikidata — Wikidata link

Cannabigerolic acid (ChEBI:67081) — ChEBI link

Cannabigerolic acid (PubChem CID 6449999) — PubChem link

Cannabigerolic acid on NIH DSLD (US supplement label database) — NIH Dietary Supplement Label Database link

Research on Cannabigerolic acid (PubMed search) — PubMed link

Track Cannabigerolic acid with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.